|
KCTD20 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.177500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.594300E-04 |
| Normal-vs-Stage2 |
2.592000E-01 |
| Normal-vs-Stage3 |
4.213600E-01 |
| Normal-vs-Stage4 |
3.869800E-01 |
| Stage1-vs-Stage2 |
3.372600E-01 |
| Stage1-vs-Stage3 |
1.398760E-01 |
| Stage1-vs-Stage4 |
5.914800E-01 |
| Stage2-vs-Stage3 |
7.571200E-01 |
| Stage2-vs-Stage4 |
8.744200E-01 |
| Stage3-vs-Stage4 |
6.935800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.239400E-03 |
| Normal-vs-AfricanAmerican |
7.936700E-03 |
| Normal-vs-Asian |
4.579200E-01 |
| Caucasian-vs-AfricanAmerican |
6.792000E-01 |
| Caucasian-vs-Asian |
9.541000E-01 |
| AfricanAmerican-vs-Asian |
9.265800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.7244999999928E-05 |
| Normal-vs-Female |
9.588200E-01 |
| Male-vs-Female |
3.301700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.100440E-02 |
| Normal-vs-Extreme_Weight |
4.27050000000317E-05 |
| Normal-vs-Obese |
3.385800E-01 |
| Normal-vs-Extreme_Obese |
5.206600E-04 |
| Normal_Weight-vs-Extreme_Weight |
5.801200E-01 |
| Normal_Weight-vs-Obese |
1.734450E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.101200E-01 |
| Extreme_Weight-vs-Obese |
2.716300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.275600E-01 |
| Obese-vs-Extreme_Obese |
1.243770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.163800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.656000E-02 |
| Normal-vs-Age(61-80Yrs) |
1.769660E-04 |
| Normal-vs-Age(81-100Yrs) |
2.245200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.593400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.257820E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.768000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.342500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.568400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.550400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.50149999999361E-05 |
| Normal-VS-Type2 PRCC |
1.822630E-01 |
| Normal-VS-KIRP CIMP |
4.708800E-01 |
| Normal-VS-Unclassified PRCC |
6.179000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.291600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.423400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.208100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.908600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.391400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.557400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.769600E-04 |
| Normal-vs-N1 |
3.388800E-01 |
| Normal-vs-N2 |
7.235000E-01 |
| N0-vs-N1 |
1.855860E-02 |
| N0-vs-N2 |
4.482000E-01 |
| N1-vs-N2 |
5.333200E-01 |
|
|
